Eslicarbazepine acetate: A therapeutic agent of paramount importance in acute anticonvulsant therapy

Journal Title: Journal of Acute Disease - Year 2017, Vol 6, Issue 6

Abstract

Eslicarbazepine acetate (ESL) is a new, once daily, orally administered, third generation antiepileptic drug which is indicated in the treatment of partial-onset seizures. ESL is known to exert it’s anticonvulsant effect by blocking the voltage-gated sodium channels. Several clinical trials and pharmacological studies have revealed that seizure control was better with ESL monotherapy (1 200 or 1 600 mg once daily) following a switch from other antiepileptic drugs in comparison with pseudo-placebo patients. The studies have indicated the ESL to be well tolerated and produced only mild to moderate emergent adverse events with the therapy. Being a dibenzazepine family member, structure and chemistry of ESL resembles more or less to carbamazepine and oxcarbazepine. ESL differs structurally from carbamazepine and oxcarbazepine at the 10, 11 position of dibenazepine nucleus. This molecular variation results in differences in metabolism and thus helps to prevent the formation of toxic epoxide metabolites. ESL following oral administration is rapidly metabolised to active metabolite namely S-licarbazepine which is responsible for its pharmacological activity. ESL exhibits acceptable pharmacokinetic profile and shows insignificant drug-drug interactions. In phase III clinical program, ESL was found to be efficacious and well tolerated in adult patients with partial onset seizures previously not controlled with treatment with one or two other antiepileptic drugs.

Authors and Affiliations

Farah Iram

Keywords

Related Articles

Comparison of inhibitory effect between DL-tryptophan and lactoferrin on Pseudomonas aeruginosa biofilm formation in wound dressing

Objective: To compare the inhibitory effect between DL-tryptophan and bovine lactoferrin on biofilm formed by isolated Pseudomonas aeruginosa strains. Methods: The study was carried out on 40 patients suffering from surg...

Noninvasive ventilation in cancer children with acute respiratory failure

Objective: To establish the effectiveness of noninvasive ventilation in cancer children with acute respiratory failure. Methods: The data of 33 cancer patients were obtained prospectively from six different pediatric in...

Traditional Chinese medicine and its protective function over brain-injured patients

Acupuncture is actually convoked for supporting Western Medicine. Its “Golden Points” can undoubtedly help patients during its neurological recovery. After almost thirty years of experience in saving patients at impendin...

Polymorphism of hypoxia-inducible factor-1毩 gene in pediatric acute respiratory distress syndrome

Objective: To examine if hypoxia-inducible factor-1毩 (Hif-1毩) polymorphisms are associated with pediatric acute respiratory distress syndrome (PARDS). Methods: Twenty two patients with PARDS and 11 non-PARDS controls w...

Cranio-cervical bone hyperpneumatization: An overview and illustrative case

The pneumatization of regions such as the apex of the temporal crag, the mastoid cells and the perilaberytic region is considered physiological in adults. The process of craniocervical pneumatization in unhealthy adults...

Download PDF file
  • EP ID EP249487
  • DOI 10.4103/2221-6189.221287
  • Views 116
  • Downloads 0

How To Cite

Farah Iram (2017). Eslicarbazepine acetate: A therapeutic agent of paramount importance in acute anticonvulsant therapy. Journal of Acute Disease, 6(6), 245-254. https://europub.co.uk/articles/-A-249487